AMMAN —
Director-General of the
King Hussein Cancer Center Asem Al-Mansour said that a
drug used in a trial therapy which cured rectal cancer in patients is
promising, according to a local news outlet.
اضافة اعلان
A group of 18
people were administered the drug, called Dostarlimab, for six months and it
was seen that the tumors had disappeared, according to last week’s news reports
in
US medical journals, which called the drug “miraculous”. The patients had
rectal cancer.
Mansour said Monday
that during the next two to three years, there will be accurate treatments for
many types of cancer targeting a specific mutation with a very high response
rate, and with minor side effects.
Mansour noted that these treatments are very expensive, and
their value may reach $7,000 to 10,000 per month, and that they will be given
for at least six months. He suggested that many countries may be unable to
afford this drug, unless there is a serious global movement that forces
pharmaceutical companies to help patients.
Read more National news
Jordan News
.jpg)
.jpg)
